Alessandro Mariani

Prof. Alessandro Mariani

Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2022 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
EBEihab O Bedawi
Eihab O Bedawi
Sara RicciardiSara Ricciardi
Sara Ricciardi
MHMaged Hassan
Maged Hassan
MGMichael R. Gooseman
Michael R. Gooseman
RARachelle Asciak
Rachelle Asciak
NRNajib Rahman
Najib Rahman
Objective Vulvar squamous cell carcinoma and in situ lesions can be stratified by human papillomavirus (HPV) and TP53 status into prognostic risk groups using p16 and p53 immunohistochemistry. We assessed the significance of vulvar squamous cell carcinoma resection margin positivity for either differentiated vulvar intra-epithelial neoplasia (dVIN) or abnormal p53 immunohistochemistry, and other pathologic variables, in a cohort of patients with HPV-independent (HPV-I) p53 abnormal (p53abn) vulvar squamous cell carcinomas. Methods Patients with stage I–II HPV-I p53abn vulvar squamous cell carcinoma with negative invasive margins who did not receive adjuvant radiation from a single institution were included. Tumors underwent margin reassessment using p53 immunohistochemistry. Cases were segregated into (1) morphologic dVIN at margin; or (2) abnormal p53 immunohistochemistry staining at margin without morphologic dVIN (p53abn immunohistochemistry); or (3) margins negative by morphology and p53 immunohistochemistry. Clinicopathologic/outcome data were collected. Results A total of 51 patients were evaluated: (1) 12 with dVIN on margin; (2) 12 with p53abn immunohistochemistry on margin without morphologic dVIN; and (3) 27 with margins negative for morphologic dVIN and p53abn immunohistochemistry. The recurrence rate for patients with dVIN or p53abn immunohistochemistry on the margin was equally high at 75% each, compared with 33% with margins negative for morphologic dVIN and p53abn immunohistochemistry (p=0.009). On multivariate analysis, positive in situ margins maintained an association with disease recurrence (p=0.03) whereas invasive margin distance (radial and deep), lymphovascular invasion, and tumor size did not. Conclusions Patients with stage I–II HPV-I vulvar squamous cell carcinoma with margins positive for either dVIN or p53abn immunohistochemistry without morphologic dVIN showed increased disease recurrence, regardless of invasive margin distance. These findings show that p53 immunohistochemistry is a useful adjunct for evaluating margin status in HPV-I vulvar squamous cell carcinoma and may support repeat excision for positive in situ margins (dVIN or p53abn immunohistochemistry).

1 April 2009 in Transplantation Proceedings
Verified
Journal Article
Closed access
MSM.N. Samano
M.N. Samano
HMH. Minamoto
H. Minamoto
JJJ.J.M. Junqueira
J.J.M. Junqueira
KYK.G.R. Yamaçake
K.G.R. Yamaçake
HGH.A.P. Gomes
H.A.P. Gomes
FJF.B. Jatene
F.B. Jatene

1 March 2012 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
IMIsrael Lopes Medeiros
Israel Lopes Medeiros
PPPaulo Manuel Pêgo-Fernandes
Paulo Manuel Pêgo-Fernandes
AMAlessandro Mariani
Alessandro Mariani
FFFlávio Guimarães Fernandes
Flávio Guimarães Fernandes
FUFernando Do Vale Unterpertinger
Fernando Do Vale Unterpertinger
FJFabio Biscegli Jatene
Fabio Biscegli Jatene

1 January 2014 in Sao Paulo Medical Journal
Verified
Journal Article
Open access
PDF file
AMAlessandro Mariani
Alessandro Mariani
PPPaulo Manuel Pêgo-Fernandes
Paulo Manuel Pêgo-Fernandes
The main advantage of RCTs is that they provide better control over possible bias through randomization and blinding. In other words, the great strength of an RCT is its high internal validity. On the other hand, rigid design control could reduce the ability to generalize the results.1 Another issue relating to RCTs is the fact that recruitment, randomization and blinding are not always possible because of technical issues (e.g. surgical procedures) or ethical issues (e.g. in a hypothetical trial to prove the association between smoking and lung cancer, it would be unethical to randomly assign a group to smoke).

14 April 2021 in Asian Cardiovascular and Thoracic Annals
Verified
Journal Article
Open access
PDF file
JBJoão Toscano de Brito
João Toscano de Brito
PGPaulo Gregório
Paulo Gregório
AMAlessandro Mariani
Alessandro Mariani
PDPaula D’ambrosio
Paula D’ambrosio
MFMauro Filho
Mauro Filho
PPPaulo Manuel Pêgo-Fernandes
Paulo Manuel Pêgo-Fernandes
Aim: Pneumomediastinum (PM) is associated with several etiologies and mechanisms. Although it has been described more than 100 years ago, the literature is limited to small retrospective studies. This study aimed to follow patients with coronavirus disease (COVID-19) that developed PM during hospitalization and describe their clinical and radiological evolution. Methods: A prospective cohort was developed with patients with PM, excluding those with aerodigestive trauma, inside a hospital COVID-19 dedicated hospital. Clinical variables including onset of symptoms, hemodynamic instability, associated complications, the need of interventions, and disease course were all recorded. Also, radiological findings such as the presence of the Macklin effect, extension of lung involvement by COVID-19, and characteristics of the PM were analyzed. Results: Twenty-one patients with non-traumatic PM were followed, resulting in an overall incidence of 0.5% during the study period. Seven (33%) patients had associated pneumothorax and malignant/tension PM was observed in three (14%) cases. The Macklin effect could be found in 11 patients (52%) and the majority of them had more than 50% of lung involvement due to COVID-19. The mortality rate was 49%; however, no deaths were directly related to the PM. Conclusions: PM incidence is probably increased in the severe acute respiratory syndrome caused by COVID-19, especially in those with greater involvement of the lungs, and the Macklin effect may be an important underlying mechanism of this complication. Usually, PM has a benign course, but complications like tension/malignant PM may occur requiring prompt detection and intervention.

8 May 2018 in Respiratory Research
Verified
Journal Article
Open access
PDF file
ENEllen Caroline Toledo Do Nascimento
Ellen Caroline Toledo Do Nascimento
BBBruno Guedes Baldi
Bruno Guedes Baldi
AMAlessandro Mariani
Alessandro Mariani
RARaquel Annoni
Raquel Annoni
RKRonaldo Adib Kairalla
Ronaldo Adib Kairalla
MDMarisa Dolhnikoff
Marisa Dolhnikoff
Lymphangioleiomyomatosis (LAM) is a low-grade neoplasm characterized by the pulmonary infiltration of smooth muscle-like cells (LAM cells) and cystic destruction. Patients usually present with airway obstruction in pulmonary function tests (PFTs). Previous studies have shown correlations among histological parameters, lung function abnormalities and prognosis in LAM. We investigated the lung tissue expression of proteins related to the mTOR pathway, angiogenesis and enzymatic activity and its correlation with functional parameters in LAM patients. We analyzed morphological and functional parameters of thirty-three patients. Two groups of disease severity were identified according to FEV1 values. Lung tissue from open biopsies or lung transplants was immunostained for SMA, HMB-45, mTOR, VEGF-D, MMP-9 and D2-40. Density of cysts, density of nodules and protein expression were measured by image analysis and correlated with PFT parameters. There was no difference in the expression of D2-40 between the more severe and the less severe groups. All other immunohistological parameters showed significantly higher values in the more severe group (p ≤ 0.002). The expression of VEGF-D, MMP-9 and mTOR in LAM cells was associated with the density of both cysts and nodules. The density of cysts and nodules as well as the expression of MMP-9 and VEGF-D were associated with the impairment of PFT parameters. Severe LAM represents an active phase of the disease with high expression of VEGF-D, mTOR, and MMP-9, as well as LAM cell infiltration. Our findings suggest that the tissue expression levels of VEGF-D and MMP-9 are important parameters associated with the loss of pulmonary function and could be considered as potential severity markers in open lung biopsies of LAM patients.